Matinas Biopharma Holdings Inc. (NYSE AMERICAN: MTNB)
$0.18
+0.0019 ( +1.04% ) 2.0M
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
Market Data
Open
$0.18
Previous close
$0.18
Volume
2.0M
Market cap
$46.78M
Day range
$0.18 - $0.19
52 week range
$0.11 - $0.89
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | May 09, 2024 |
| 10-q | Quarterly Reports | 68 | May 09, 2024 |
| 8-k | 8K-related | 20 | Apr 05, 2024 |
| 8-k | 8K-related | 43 | Mar 28, 2024 |
| 10-k | Annual reports | 89 | Mar 27, 2024 |
| 8-k | 8K-related | 15 | Mar 27, 2024 |
| 8-k | 8K-related | 17 | Mar 25, 2024 |
| 8-k | 8K-related | 15 | Mar 22, 2024 |
| 8-k | 8K-related | 15 | Mar 22, 2024 |
| 8-k | 8K-related | 16 | Feb 26, 2024 |